BEXINE Antitussif Butamirate siroup 1.5 mg/ml 200
7680696880013
CH-69688
R05DB13
03.01.2.
1 / 3
google
Details
- Product number
- 6968801
- CPT
- -
- Packaging group
- 200
- Unit
- ml
- Composition
- butamirati dihydrogenocitras 1.5 mg/ml, sorbitolum liquidum non cristallisabile 415.10 mg/ml, saccharinum natricum, natrii benzoas 1.1325 mg/ml, vanillinum, acidum hydrochloridum concentratum, natrii hydroxidum, aqua purificata ad solutionem pro 1 ml corresp. natrium 0.25 mg.
Articles (1)
Bexin Hustenstiller Butamirat, Sirup
Sirup
200
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
1.5 MGML | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
415.1 MGML | Substance | HBESI |
|
(N/A)
|
- | Substance | AIMDK |
|
(N/A)
|
1.1325 MGML | Substance | HBESI |
|
(N/A)
|
- | Substance | AIMDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.25 MG | Substance | HBESI |
Authorization holder
Spirig HealthCare AG
4622 Egerkingen
Authorization information
- Swissmedic authorization number
- 69688
- Drug name
- Bexin Hustenstiller Butamirat, Sirup
- Galenic form
- SIRU
- ATC Code
- R05DB13
- Authorization status
- Z
- Dispensation category
- D
- First authorization
- 06/03/2025
- Authorization expiration date
- 05/03/2030
- IT number
- 03.01.2.
- Domain
- Human medicine
Packaging details
- Description (FR)
- BEXINE Antitussif Butamirate siroup 1.5 mg/ml 200
- Description (DE)
- BEXIN Hustenstiller Butamirat Sirup 1.5 mg/ml 200
- Market launch
- 03/09/2025
- Narcotic (BTM)
- No